<DOC>
	<DOC>NCT01309074</DOC>
	<brief_summary>The aim of the study is to compare the safety &amp; efficacy of sertraline (up to a dose of 200mg/day) &amp; pregabalin (up to a dose of 300mg/day)for the treatment of symptoms of anxiety in patients with epilepsy.</brief_summary>
	<brief_title>Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>GAD7 total score above 10. Have a diagnosis of a Partial Seizure Disorder. Have a HamiltonA total score 20 and above. 1880 years of age. Able to read at a fourth grade level. If a woman of childbearing age, agrees to use an acceptable means of birth control. Unable to understand and sign a consent. Unable to follow instructions for the study. Displaying current suicidal ideation Having psychogenic nonepileptic seizures Have a history of drug or alcohol abuse. Use of any investigational drug within the last 30 days. Hypersensitivity reaction or other serious adverse event to PGB in prior trials.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Anxiety</keyword>
	<keyword>Epilepsy</keyword>
</DOC>